Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,504 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

NCT06672146

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 136 locations
View Trial Details
Recruiting

Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

NCT07478991

Conditions
Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Complejo Hospitalario Universitario de A Coruña Santiago de Compostela, A Coruña, Spain
  • ICO Hospitalet- Hospital Duran i Reynals Hospitalet Del Llobregat, Barcelona, Spain
  • Hospital Mútua de Terrassa Terrassa, Barcelona, Spain
  • Complejo Hospitalario de Jaén Jaén, Jaen, Spain
View all 51 locations
View Trial Details
Recruiting

A Study of CRD3874-SI in People With Leukemia

NCT07661095

Conditions
AML, Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

NCT06284486

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

NCT06191263

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Centre Hospitalier Universitaire Grenoble Alpes Grenoble, France
  • Centre Hospitalier Le Mans Le Mans, France
  • Centre Hospitalier Universitaire De Lille Lille, France
  • Institut Paoli-Calmettes Marseille, France
View all 37 locations
View Trial Details

Related conditions